Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech

Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech

Source: 
Xconomy
snippet: 

Roche will pay Amunix Pharmaceuticals $40 million up front to use the company’s proprietary technology to discover and develop new drugs outside of the oncology space.